We are live on ! Find out more
GACM

Green Arrow Capital Management Portfolio holdings

AUM $535M
1-Year Est. Return 14.21%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+14.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.19B
AUM Growth
+$395M
Cap. Flow
+$386M
Cap. Flow %
32.41%
Top 10 Hldgs %
34.77%
Holding
256
New
94
Increased
38
Reduced
29
Closed
87

Sector Composition

Rank Sector Weight
1 Utilities 25.29%
2 Energy 10.74%
3 Healthcare 7.35%
4 Technology 6.2%
5 Industrials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAS icon
126
Masco
MAS
$15.3B
$1.66M 0.14%
78,768
-106,068
-57% -$2.1M
RAX
127
CALL
DELISTED
Rackspace Hosting Inc
RAX
$1.63M 0.14%
+50,000
New +$1.66M
QEP
128
CALL
DELISTED
QEP RESOURCES, INC.
QEP
$1.57M 0.13%
+51,000
New +$1.71M
CAH icon
129
Cardinal Health
CAH
$55.4B
$1.5M 0.13%
+20,000
New +$1.46M
ABT icon
130
CALL
Abbott
ABT
$187B
$1.46M 0.12%
35,000
BKD icon
131
Brookdale Senior Living
BKD
$3.4B
$1.45M 0.12%
+45,000
New +$1.53M
GNC
132
DELISTED
GNC Holdings, Inc.
GNC
$1.36M 0.11%
+35,000
New +$1.27M
WLKP icon
133
Westlake Chemical Partners
WLKP
$763M
$1.33M 0.11%
+45,900
New +$1.39M
HUM icon
134
Humana
HUM
$46.2B
$1.3M 0.11%
10,000
BELFB
135
Bel Fuse Inc Class B
BELFB
$4.21B
$1.3M 0.11%
52,500
+10,500
+25% +$253K
CTRX
136
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$1.26M 0.11%
30,000
-45,000
-60% -$2.05M
MPC icon
137
Marathon Petroleum
MPC
$83.7B
$1.23M 0.1%
+29,140
New +$1.24M
PDCE
138
DELISTED
PDC Energy, Inc.
PDCE
$1.22M 0.1%
+24,239
New +$1.37M
MHGC
139
DELISTED
Morgans Hotel Group Co.
MHGC
$1.21M 0.1%
150,000
+40,000
+36% +$310K
TTPH
140
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.2M 0.1%
3,000
ABBV icon
141
AbbVie
ABBV
$435B
$1.12M 0.09%
19,446
-30,554
-61% -$1.7M
NFX
142
DELISTED
Newfield Exploration
NFX
$1.06M 0.09%
+28,704
New +$1.19M
SRPT icon
143
Sarepta Therapeutics
SRPT
$1.77B
$1.05M 0.09%
+50,000
New +$1.13M
NPSP
144
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.04M 0.09%
+40,000
New +$1.15M
ASPX
145
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.03M 0.09%
+40,000
New +$851K
INFI
146
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.01M 0.08%
+75,000
New +$893K
PETM
147
DELISTED
PETSMART INC
PETM
$981K 0.08%
+14,000
New +$974K
SMA
148
DELISTED
SYMMETRY MEDICAL INC
SMA
$898K 0.08%
+89,000
New +$824K
HZNP
149
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$860K 0.07%
+70,000
New +$813K
SWY
150
DELISTED
SAFEWAY INC
SWY
$799K 0.07%
23,286
-353,703
-94% -$12.2M

Similar funds

Green Arrow Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Green Arrow Capital Management held 256 positions worth $1.19B, up 50% from $795M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Green Arrow Capital Management deployed $386M of net new capital in Q3 2014, opening 94 new positions and adding to 38 existing holdings. Its largest new stake was TIM HORTONS INC COM, CANADA: 428,766 shares worth $33.8M.

By sector, the portfolio is most concentrated in Utilities at 25% of assets, down from 30% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was TIME WARNER CABLE INC NEW COM STK, an estimated $15.7M trimmed.

  • Green Arrow Capital Management's largest Q3 2014 buy was TIM HORTONS INC COM, CANADA: 428,766 shares worth $33.8M.
  • Green Arrow Capital Management added most to Brightstar Lottery PLC in Q3 2014, an estimated $24.8M increase.
  • Green Arrow Capital Management's biggest Q3 2014 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $15.7M.
  • Green Arrow Capital Management fully exited OPENTABLE,INC COMMON STOCK in Q3 2014, selling an estimated $15.9M.
  • Green Arrow Capital Management's ten largest holdings make up 35% of its $1.19B portfolio in Q3 2014.
  • Green Arrow Capital Management opened 94 new positions and closed 87 in Q3 2014.
  • Green Arrow Capital Management's portfolio value rose 50% quarter-over-quarter to $1.19B.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.